Tips for Presenting in Public
At some point in your life, you’ll probably face having to do something most people consider one of their biggest fears: public speaking. And although many people dread presentations, many careers now require some form of public speaking — making presentation skills a must.
Luckily, there’s lots of great advice online to help you prepare for an upcoming public speaking engagement.
Below are five tips to help you nail your next presentation:
- Focus On The Topic At Hand1We’ve all experienced those presentations that lose our interest within the first five minutes. You can avoid this by focusing your presentation on easy-to-follow points accompanied by supporting logic. This will also help you avoid rambling during your presentation.
- Include Personal Stories1To really command your audience’s attention, you need to connect with them on an emotional level. One of the most effective ways to do this is to share a personal story. The more personal your story, the higher chance you have of influencing your audience1.
- Make it Visual1Images, graphics and videos can be used to enhance a PowerPoint presentation1. When formatting your slides, try to use bullet points to summarize key points rather than large blocks of text — and use images to reinforce those points. Just remember that supporting visuals should never distract the audience from the main attraction: you1.
- Watch Your Body Language2Body language can speak volumes during presentations, so it’s important to take note of what your body might be telling the audience2. When you practice your presentation, stand in front of a mirror or videotape yourself so you can identify potential body language issues. Hand gestures should be used to emphasize specific points, and eye contact should be made when necessary2.
- Animate Your Voice2You can enhance your presentation by using different tones, speeds and dramatic pauses throughout your speech2. This will help you maintain a high level of energy, as well as your audience’s full attention.
In addition to the tips outlined above, there are other steps you can take to help reduce the chance of something going wrong on the day of your presentation, since stress can be a trigger for cold sores.
For example, frequent cold sore sufferers may want to have Sitavig® (acyclovir), 50mg Muco-Adhesive Buccal Tablet on hand during more stressful times in their lives. Sitavig is an FDA-approved, single-dose prescription cold sore treatment that can ease cold sore symptoms, speed up healing, and in some cases, stop cold sores before they start.
If you’ve got an important presentation coming up and you feel like you may be getting a cold sore, find a Sitavig prescribing physician near you to find out if prescription Sitavig can help.
- Inc. (July 2, 2013). 5 Tips for Giving Really Amazing Presentations. Retrieved June 21, 2016 from http://www.inc.com/kevin-daum/5-tips-for-giving-really-amazing-presentations.html
- Forbes (July 22, 2014). 7 Advanced Presentation Tips To Become a Great Public Speaker. Retrieved June 21, 2016 from http://www.forbes.com/sites/carminegallo/2014/07/22/7-advanced-presentation-tips-to-become-a-great-public-speaker/#28ba46f87eb1
Indication & Important Safety Information
Sitavig® (acyclovir) 50 mg buccal tablet is indicated for
the treatment of recurrent herpes labialis (cold sores) in immunocompetent
IMPORTANT SAFETY INFORMATION
- Sitavig® (acyclovir) 50 mg buccal tablet should not be used in patients with known hypersensitivity to acyclovir, milk protein concentrate, or any other component of the product.
- Sitavig has not been studied in immunocompromised patients. No interaction studies have been performed. Sitavig’s safety and efficacy have not been established in pediatric patients.
- There are no available data on Sitavig use in pregnant women. However, published observational studies over decades of use of acyclovir have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. It is not known if Sitavig is excreted in breast milk; however, systemic exposure following buccal administration of acyclovir is minimal. Before administration, discuss if the patient is lactating or planning to breastfeed.
- The possibility of viral resistance to acyclovir should be considered in patients who fail to respond or experience recurrent viral shedding during therapy.
- In a controlled clinical trial, the most common side effects (greater than or equal to 1%) for Sitavig were: headache (3%), dizziness (1%), lethargy (1%), gingival (gum) pain (1%), aphthous stomatitis (canker
sores) (1%), application site pain (1%), application site irritation (1%), erythema (redness) (1%), and rash (1%). In the same trial, these side effects ranged from 0% to 3% for placebo.
You are encouraged to report negative side effects of prescription
drugs to the FDA. Call
1-800-FDA-1088 or visit www.fda.gov/medwatch.
Please see Full Prescribing Information.